Karlsruhe Institute of Technology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Karlsruhe Institute of Technology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9399
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Karlsruhe Institute of Technology (KIT) is an educational service provider that offers research based scientific education. The institute offers research programs in the areas of biology, chemistry, and process engineering, mechanical and electrical engineering, physics and mathematics, natural and built environment, and informatics, economics, society, and others. It also offers innovation management, and protection of intellectual property rights through the technology marketing and project initiation, negotiation of license agreements, and initiation and support of IP-based spinoffs, start-ups and shareholdings. The institute offers research services such as advice for politicians, research funding, technology transfer and technical services. It operates institutes for applied business studies and management, applied materials, human and industrial engineering, vocational and general education, process engineering in life sciences, and telematics and transport studies, among others. KIT is headquartered in Karlsruhe, Germany.

Karlsruhe Institute of Technology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
amcure Raises USD6.4 Million in Series B Financing 10
Equity Offering 12
Lumobiotics Spin-Off from Karlsruhe Institute of Technology 12
amcure Spin-Off from from Karlsruhe Institute of Technology 13
Karlsruhe Institute of Technology – Key Competitors 14
Karlsruhe Institute of Technology – Key Employees 15
Karlsruhe Institute of Technology – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Sep 06, 2017: Bone Marrow Models to Study Blood and Musculoskeletal Disorders 17
Other Significant Developments 18
Sep 27, 2017: Merck Provides Update on EU’s Horizon 2020 Program to Improve Biopharmaceutical Downstream Processing 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Key Facts 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Karlsruhe Institute of Technology, Deals By Therapy Area, 2012 to YTD 2018 8
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
amcure Raises USD6.4 Million in Series B Financing 10
Lumobiotics Spin-Off from Karlsruhe Institute of Technology 12
amcure Spin-Off from from Karlsruhe Institute of Technology 13
Karlsruhe Institute of Technology, Key Competitors 14
Karlsruhe Institute of Technology, Key Employees 15
Karlsruhe Institute of Technology, Other Locations 16
Karlsruhe Institute of Technology, Subsidiaries 16

List of Figures
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Karlsruhe Institute of Technology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orange Belgium (OBEL):企業の財務・戦略的SWOT分析
    Orange Belgium (OBEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TenCate Advanced Armour:企業の戦略・SWOT・財務分析
    TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report Summary TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Zignago Vetro SpA:企業の戦略・SWOT・財務情報
    Zignago Vetro SpA - Strategy, SWOT and Corporate Finance Report Summary Zignago Vetro SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Taisei Corporation:企業の戦略・SWOT・財務分析
    Taisei Corporation - Strategy, SWOT and Corporate Finance Report Summary Taisei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lea County Electric Cooperative Inc:企業の戦略的SWOT分析
    Lea County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Atlantic Pro-Nutrients Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atlantic Pro-Nutrients Inc (APN) is a health science company that manufactures dietary supplements and functional foods. The company offers products in the areas of women's health, men's health, sports nutrition, immune health, cytokine balance support, adrenal support, antioxidants, bone he …
  • Paramo AS:企業の戦略的SWOT分析
    Paramo AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Alnylam Pharmaceuticals Inc (ALNY):製薬・医療:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • Seair Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Seair Inc, doing business as Dover Water Solutions, is a clean technology company that carries out research and development, production and sale of gas diffusion technologies. It focuses on commercializing advanced waste water and industrial fluid treatment solutions. The company offers high …
  • Centauri Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Centauri Therapeutics Ltd (Centauri Therapeutics) is a biotechnology company that discovers and develops novel molecules for life threatening diseases. The company uses alphamer technology to develop anti-infective therapeutics. Its alphamer technology is based on programmable immunity in wh …
  • EOG Resources, Inc.:企業の戦略・SWOT・財務情報
    EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • AJ Lucas Group Ltd (AJL)
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Mologic Ltd:企業の製品パイプライン分析2018
    Summary Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures and markets in vitro diagnostic medical devices. The company provides products such as bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit and FMLP ELISA kit, amon …
  • Xylem Inc (XYL):電力:M&Aディール及び事業提携情報
    Summary Xylem Inc (Xylem) is a water technology company. It designs, manufactures, and services engineered solutions ranging across a wide variety of applications. The company’s offerings address customer needs across the water cycle, from the delivery, measurement and use of drinking water to the c …
  • Finnair Oyj:企業のM&A・事業提携・投資動向
    Finnair Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finnair Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Fri-El Green Power SpA-エネルギー分野:企業M&A・提携分析
    Summary Fri-El Green Power SpA (Fri-El) is a renewable energy company that offers production of electric energy from renewable sources. The company develops, builds and manages power stations fuelled with biogas. Its wind energy is produced through wind turbine generators that convert wind to kineti …
  • Idaho Power Co:企業の戦略的SWOT分析
    Idaho Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • RIKEN:製薬・医療:M&Aディール及び事業提携情報
    Summary RIKEN is a research organization that carries out basic and applied science research programs. The organization’s research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, resear …
  • Pizza Inn, Inc:企業の戦略・SWOT・財務情報
    Pizza Inn, Inc - Strategy, SWOT and Corporate Finance Report Summary Pizza Inn, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Columbia University-製薬・医療分野:企業M&A・提携分析
    Summary Columbia University (CU) is an educational service provider that offers educational and research programs. The university provides educational services and courses through its schools, departments, faculties, centers and institutes. It provides undergraduate and graduate courses in various d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆